π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The study will assess the efficacy of PPI-668 (USAN: ravidasvir hydrochlori...
Status
Unknown
Location
Al-Qahira Al-Fatimeya MoH Hospital
Start Date
2015-01
Trial ID
NCT02371408
Treatments Being Tested
This is a Phase II/III, multicenter, multi-country, trial to assess the eff...
Status
Unknown
Location
Hospital Sultanah Aminah
Start Date
2016-09
Trial ID
NCT02961426
Treatments Being Tested
This study will compare the blood levels of PPI-668 resulting from two diff...
Status
Completed
Location
Buffalo Clinical Research Center
Start Date
2014-10
Trial ID
NCT02258321
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics and safety of...
Status
Completed
Location
First Hospital of Zhejiang Province
Start Date
2018-01-15
Trial ID
NCT03430830
Treatments Being Tested
This study will follow a group of people with chronic hepatitis C infection...
Status
Active Not Recruiting
Location
Center of Target Therapy LLC.
Start Date
2025-09-17
Trial ID
NCT07316842
PPI-668 is an antiviral agent (a hepatitis C NS5A inhibitor) that is being ...
Status
Completed
Location
Investigational site
Start Date
2011-10
Trial ID
NCT01448200
The primary objectives of the study are to: * Evaluate the potential effec...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2013-02
Trial ID
NCT01786382
Treatments Being Tested
In a phase 1, open-label, crossover study to evaluate the relative bioavail...
Status
Completed
Location
Ampang hospital
Start Date
2018-06-05
Trial ID
NCT03602300
The purpose of this study is to evaluate the Pharmacokinetics and safety of...
Status
Completed
Location
Multiple Locations
Start Date
2016-07-15
Trial ID
NCT03020134
Treatments Being Tested
The purpose of this study is to investigate the Pharmacokinetics and Safety...
Status
Completed
Location
The first hospital of Zhejiang province
Start Date
2017-08-08
Trial ID
NCT03288636
Treatments Being Tested